Literature DB >> 12431223

Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice.

Siân Clarke1, Traci Czyzyk, Micheal Ansonoff, Joshua F Nitsche, Ming-Sing Hsu, Linda Nilsson, Kerstin Larsson, Anna Borsodi, Geza Toth, Ray Hill, Ian Kitchen, John E Pintar.   

Abstract

Three genes for the opioid receptors ( micro, delta and kappa) and a gene coding for a related receptor (ORL1) have been cloned but pharmacological studies suggest that further subtypes exist that remain poorly understood. To determine if there are other classically defined opioid binding sites we have carried out homogenate binding and section autoradiography with [3H]naloxone in mice that lack all three opioid genes and are hyperalgesic in a thermal nociceptive test. We have also examined [3H]bremazocine labelling in triple knockout brain and spinal cord as this ligand has been proposed to label novel kappa-receptors. No receptor labelling for either ligand was detected in the brains or spinal cord of knockout mice demonstrating that all binding is the product of the three known receptors and that there is no cross-labelling of the ORL1 receptor. Nociceptin (1 micro m) caused marked displacement of [3H]bremazocine in wild-type brains indicating that nociceptin at high concentrations can displace classical opioid binding. As a number of studies have proposed a close association between the classical opioid receptors and the ORL1 system we also hypothesized that loss of all of the classical opioid receptors might lead to compensatory changes in ORL1 receptors. Labelling of the ORL1 receptor with [3H]nociceptin showed region-dependent quantitative increases in triple knockout brains indicating a close relationship between the two systems in specific brain areas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431223     DOI: 10.1046/j.1460-9568.2002.02239.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  Duration of action of a broad range of selective κ-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation.

Authors:  Erica J Melief; Mayumi Miyatake; F Ivy Carroll; Cécile Béguin; William A Carlezon; Bruce M Cohen; Sarah Grimwood; Charles H Mitch; Linda Rorick-Kehn; Charles Chavkin
Journal:  Mol Pharmacol       Date:  2011-08-10       Impact factor: 4.436

2.  Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.

Authors:  Selena S Schattauer; Jamie R Kuhar; Allisa Song; Charles Chavkin
Journal:  Cell Signal       Date:  2017-01-11       Impact factor: 4.315

Review 3.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 4.  Challenges for opioid receptor nomenclature: IUPHAR Review 9.

Authors:  Brian M Cox; Macdonald J Christie; Lakshmi Devi; Lawrence Toll; John R Traynor
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

5.  Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.

Authors:  Jay P McLaughlin; Lisa C Myers; Paul E Zarek; Marc G Caron; Robert J Lefkowitz; Traci A Czyzyk; John E Pintar; Charles Chavkin
Journal:  J Biol Chem       Date:  2003-11-03       Impact factor: 5.157

6.  Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse.

Authors:  Victor M Navarro; Michelle L Gottsch; Charles Chavkin; Hiroaki Okamura; Donald K Clifton; Robert A Steiner
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

7.  Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.

Authors:  Michael R Bruchas; Benjamin B Land; Megumi Aita; Mei Xu; Sabiha K Barot; Shuang Li; Charles Chavkin
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

8.  Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.

Authors:  Michael R Bruchas; Mei Xu; Charles Chavkin
Journal:  Neuroreport       Date:  2008-09-17       Impact factor: 1.837

9.  Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice.

Authors:  V I Chefer; T S Shippenberg
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

10.  Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.

Authors:  Michael R Bruchas; Tao Yang; Selena Schreiber; Mia Defino; Steven C Kwan; Shuang Li; Charles Chavkin
Journal:  J Biol Chem       Date:  2007-08-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.